SynthesisHepatology international2020

Tenofovir versus entecavir in lowering the risk of hepatocellular carcinoma development in patients with chronic hepatitis B: a critical systematic review and meta-analysis.

Min Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.